Author

Pradeep Khanal

Institutions: Henry Ford Health, Henry Ford Hospital

Observed institutions: Trinity Health, Patan Academy of Health Sciences, Bronson Methodist Hospital, Henry Ford Health, Oregon Health & Science University, Henry Ford Hospital, Trinity Health Ann Arbor Hospital, St. Mary Mercy Livonia, Beaumont Hospital, Royal Oak, Corewell Health William Beaumont University Hospital, OHSU Knight Cancer Institute

OpenAlex ID: A5113227754

Early, Isolated Duodenal Mucosa-Associated Lymphoid Tissue Lymphoma Presenting without Symptoms or Grossly Apparent Endoscopic Lesions and Diagnosed by Random Duodenal Biopsies

2016 · Mihajlo Gjeorgjievski, Issa Makki, et al. · Case Reports in Gastroenterology · 5

Severe Lactic Acidosis and Hypoglycemia Associated With Burkitt Lymphoma and the Warburg Effect

2024 · Pradeep Khanal, Ashbita Pokharel, et al. · Cureus · 4

A Retrospective Study Analyzing the Appropriateness of Initial Treatment of Clostridium difficile in Patients with Active Malignancy

2018 · Aaron Fisher, Pradeep Khanal, et al. · Gastroenterology Research and Practice · 3

Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent

2026 · Pradeep Khanal, Suhail Sapkota, et al. · Cureus · 1

Walking the tightrope: acute liver rejection after chimeric antigen receptor-T cell therapy for post-transplant lymphoproliferative disorder (PTLD)—a case report

2025 · Sanjog Bastola, Manoj Rai, et al. · Annals of Lymphoma · 1

Paraneoplastic movement disorder due to suspected metastatic Leiomyosarcoma of tongue: A case report

2024 · Pradeep Khanal, Pradeep Khanal, et al. · Clinical Case Reports · 1

POSTER: MCL-1233: Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

2026 · Suhail Sapkota, Shankar Biswas, et al. · Clinical Lymphoma Myeloma & Leukemia

MCL-1233: Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

2026 · Suhail Sapkota, Shankar Biswas, et al. · Clinical Lymphoma Myeloma & Leukemia

Safety and Efficacy of Low Dose Versus High Dose Corticosteroid for Graft Versus Host Disease (GVHD): A Systematic Review

2024 · Ghulam Shah, Ahda Solangi, et al. · Blood

Safety and efficacy of low dose versus high dose corticosteroid for graft versus host disease (GVHD): A systematic review.

2024 · Pradeep Khanal, Sangam Shah · Journal of Clinical Oncology

Works count: 11

Citation count: 16

H-index: 3

I10-index: